These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 3258066)
1. Androgens stimulate both growth rate and epidermal growth factor receptor activity of the human prostate tumor cell LNCaP. Schuurmans AL; Bolt J; Mulder E Prostate; 1988; 12(1):55-63. PubMed ID: 3258066 [TBL] [Abstract][Full Text] [Related]
2. Androgen-dependent growth regulation of and release of specific protein(s) by the androgen receptor containing human prostate tumor cell line LNCaP. Berns EM; de Boer W; Mulder E Prostate; 1986; 9(3):247-59. PubMed ID: 2946029 [TBL] [Abstract][Full Text] [Related]
3. Androgens and transforming growth factor beta modulate the growth response to epidermal growth factor in human prostatic tumor cells (LNCaP). Schuurmans AL; Bolt J; Mulder E Mol Cell Endocrinol; 1988 Nov; 60(1):101-4. PubMed ID: 3265111 [TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor-dependent stimulation of amphiregulin expression in androgen-stimulated human prostate cancer cells. Sehgal I; Bailey J; Hitzemann K; Pittelkow MR; Maihle NJ Mol Biol Cell; 1994 Mar; 5(3):339-47. PubMed ID: 8049525 [TBL] [Abstract][Full Text] [Related]
5. Regulation of growth and epidermal growth factor receptor levels of LNCaP prostate tumor cells by different steroids. Schuurmans AL; Bolt J; Voorhorst MM; Blankenstein RA; Mulder E Int J Cancer; 1988 Dec; 42(6):917-22. PubMed ID: 3263955 [TBL] [Abstract][Full Text] [Related]
6. Androgens inhibit the proliferation of a variant of the human prostate cancer cell line LNCaP. Joly-Pharaboz MO; Soave MC; Nicolas B; Mebarki F; Renaud M; Foury O; Morel Y; Andre JG J Steroid Biochem Mol Biol; 1995 Oct; 55(1):67-76. PubMed ID: 7577722 [TBL] [Abstract][Full Text] [Related]
7. Androgenic and antiandrogenic control on epidermal growth factor, epidermal growth factor receptor, and androgen receptor expression in human prostate cancer cell line LNCaP. Ravenna L; Lubrano C; Di Silverio F; Vacca A; Felli MP; Maroder M; D'Eramo G; Sciarra F; Frati L; Gulino A Prostate; 1995 Jun; 26(6):290-8. PubMed ID: 7784269 [TBL] [Abstract][Full Text] [Related]
8. Stimulatory effects of antiandrogens on LNCaP human prostate tumor cell growth, EGF-receptor level and acid phosphatase secretion. Schuurmans AL; Bolt J; Veldscholte J; Mulder E J Steroid Biochem Mol Biol; 1990 Dec; 37(6):849-53. PubMed ID: 2149505 [TBL] [Abstract][Full Text] [Related]
9. Regulation of growth of LNCaP human prostate tumor cells by growth factors and steroid hormones. Schuurmans AL; Bolt J; Veldscholte J; Mulder E J Steroid Biochem Mol Biol; 1991; 40(1-3):193-7. PubMed ID: 1958520 [TBL] [Abstract][Full Text] [Related]
10. [Androgen regulation of secreted growth factors in prostate carcinoma cell and tumor lines]. Kellner U; Wagner B; Otto U; Voigt KD; Dietel M; Knabbe C Verh Dtsch Ges Pathol; 1993; 77():124-8. PubMed ID: 7511269 [TBL] [Abstract][Full Text] [Related]
11. LNCaP prostatic adenocarcinoma cells derived from low and high passage numbers display divergent responses not only to androgens but also to retinoids. Esquenet M; Swinnen JV; Heyns W; Verhoeven G J Steroid Biochem Mol Biol; 1997 Aug; 62(5-6):391-9. PubMed ID: 9449242 [TBL] [Abstract][Full Text] [Related]
12. Growth of the androgen-dependent tumor of the prostate: role of androgens and of locally expressed growth modulatory factors. Limonta P; Dondi D; Marelli MM; Moretti RM; Negri-Cesi P; Motta M J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):401-5. PubMed ID: 7626487 [TBL] [Abstract][Full Text] [Related]
13. Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity. Siu SW; Lau KW; Tam PC; Shiu SY Prostate; 2002 Jul; 52(2):106-22. PubMed ID: 12111702 [TBL] [Abstract][Full Text] [Related]
14. Androgen up-regulates epidermal growth factor receptor expression and binding affinity in PC3 cell lines expressing the human androgen receptor. Brass AL; Barnard J; Patai BL; Salvi D; Rukstalis DB Cancer Res; 1995 Jul; 55(14):3197-203. PubMed ID: 7606741 [TBL] [Abstract][Full Text] [Related]
15. ErbB1 and prostate cancer: ErbB1 activity is essential for androgen-induced proliferation and protection from the apoptotic effects of LY294002. Tørring N; Dagnaes-Hansen F; Sørensen BS; Nexø E; Hynes NE Prostate; 2003 Jul; 56(2):142-9. PubMed ID: 12746839 [TBL] [Abstract][Full Text] [Related]
16. Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells. Ripple MO; Henry WF; Rago RP; Wilding G J Natl Cancer Inst; 1997 Jan; 89(1):40-8. PubMed ID: 8978405 [TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor activation in androgen-independent but not androgen-stimulated growth of human prostatic carcinoma cells. Sherwood ER; Van Dongen JL; Wood CG; Liao S; Kozlowski JM; Lee C Br J Cancer; 1998 Mar; 77(6):855-61. PubMed ID: 9528825 [TBL] [Abstract][Full Text] [Related]
18. Regulation of androgen receptor by androgen and epidermal growth factor in a human prostatic cancer cell line, LNCaP. Mizokami A; Saiga H; Matsui T; Mita T; Sugita A Endocrinol Jpn; 1992 Jun; 39(3):235-43. PubMed ID: 1425449 [TBL] [Abstract][Full Text] [Related]